<DOC>
	<DOCNO>NCT02148627</DOCNO>
	<brief_summary>The main purpose study evaluate safety LY3041658 healthy participant , include first generation Japanese . The study also investigate drug process affect key immune cell . Study participation last 4 month . Protocol amend January , 2016 include first generation Japanese participant .</brief_summary>
	<brief_title>Safety Study LY3041658 Healthy Participants</brief_title>
	<detailed_description />
	<criteria>All : Body mass index ( BMI ) 18.0 32.0 kilogram per square meter ( kg/m² ) . Absolute neutrophil count screen ≥1.8 ≤7.2 x 10^3/microliter ( uL ) , inclusive . Firstgeneration Japanese : Participant , biological parent , biological grandparent must exclusive Japanese descent bear Japan . Are 20 65 year age , inclusive , time initial screening . Have receive antibodybased biologic agent ( market investigational ) within 3 month 5 half life ( t1/2 ) drug ( whichever longer ) prior screen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>antibody</keyword>
	<keyword>autoimmune</keyword>
</DOC>